Six of the eleven clinical trials focused on GLP-1 receptor agonists, particularly semaglutide—the active ingredient in ...

New research reveals weight-loss drugs help during treatment but weight returns rapidly after stopping. Experts urge ...

Tirzepatide was superior to semaglutide in achieving standard and intensive cardiometabolic targets among patients with type 2 diabetes.

The hormonal changes of menopause can make the weight gain more resistant to traditional diet and lifestyle changes. But GLP-1s can be an effective reinforcement of diet and exercise.

A retrospective cohort study found that semaglutide and tirzepatide are linked with significantly lower risks of dementia and ...

THEY have taken the nation’s waistlines by storm, helping thousands shed pounds and trim inches. So-called fat jabs have been dubbed a “miracle” – helping turn the tide on ...

Copycats and false advertisements are also to blame for the increased threats. Stemming from social media testimonials all ...

A new study has found that a diabetes medicine called tirzepatide can help people lower their blood sugar and lose weight ...

A WOMAN has shared the brutally honest truth about what happened when she was forced to ”go cold turkey” from Mounjaro.

For adults with type 2 diabetes and obesity, glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with a lower risk for dementia, stroke, and all-cause mortality compared with other ...

Landmark trials have shown that GLP-1 receptor agonists, originally developed for diabetes and weight loss, also provide ...

The review that pooled the results of 11 studies has found that people started regaining weight two months after stopping the ...